Richard Law

Stock Analyst at Goldman Sachs

(0.12)
# 4,376
Out of 5,041 analysts
67
Total ratings
25%
Success rate
-30.57%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Richard Law

Crinetics Pharmaceuticals
Sep 26, 2025
Maintains: Neutral
Price Target: $35$40
Current: $40.99
Upside: -2.42%
Mineralys Therapeutics
Sep 9, 2025
Maintains: Buy
Price Target: $32$52
Current: $39.90
Upside: +30.33%
Viridian Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $27$30
Current: $22.16
Upside: +35.38%
MoonLake Immunotherapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $74$82
Current: $9.52
Upside: +761.34%
Arcutis Biotherapeutics
Jul 25, 2025
Initiates: Neutral
Price Target: $18
Current: $20.11
Upside: -10.49%
Olema Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $20$18
Current: $8.03
Upside: +124.16%
Silence Therapeutics
May 9, 2025
Maintains: Sell
Price Target: $4$3
Current: $7.30
Upside: -58.90%
Rocket Pharmaceuticals
May 9, 2025
Maintains: Neutral
Price Target: $15$13
Current: $3.85
Upside: +237.66%
Celldex Therapeutics
May 9, 2025
Maintains: Neutral
Price Target: $36$31
Current: $26.72
Upside: +16.02%
Viking Therapeutics
Apr 8, 2025
Initiates: Neutral
Price Target: $30
Current: $34.42
Upside: -12.84%
Initiates: Buy
Price Target: $73
Current: $94.88
Upside: -23.06%
Reiterates: Neutral
Price Target: $11
Current: $11.14
Upside: -1.26%
Maintains: Neutral
Price Target: $46$47
Current: $27.96
Upside: +68.10%
Maintains: Neutral
Price Target: $62$63
Current: $67.61
Upside: -6.82%
Maintains: Neutral
Price Target: $36$37
Current: $58.56
Upside: -36.82%
Reiterates: Outperform
Price Target: $76
Current: $25.60
Upside: +196.88%
Maintains: Neutral
Price Target: $15$14
Current: $3.72
Upside: +276.34%
Reiterates: Outperform
Price Target: $61
Current: $9.21
Upside: +562.32%